Showing results (381-390 of 515) with videos related to
Sort By:
Pageof 52
Crohn'S & Colitis 360|October 25, 2026
Prevalence and impact of Thiopurine S-methyltransferase (TPMT) and Nudix hydrolase 15 (NUDT15) polymorphisms on the occurrence of myelosuppression in Thai patients with inflammatory bowel disease receiving thiopurine therapyRujirada Phoojaroenchanachai, Thanaboon Chaemsupaphan, Onuma Sattayalertyanyong, et al.Crohn'S & Colitis 360|September 6, 2021
Telenutrition for Inflammatory Bowel Disease: A Tipping Point for Dietary WellnessSami Elamin, Jonah CohenCrohn'S & Colitis 360|April 21, 2020
The Autoimmune Protocol Diet Modifies Intestinal RNA Expression in Inflammatory Bowel DiseaseAnita Chandrasekaran, Bhuvan Molparia, Ehsaan Akhtar, et al.Crohn'S & Colitis 360|February 17, 2023
Patients' Preference of Topical Therapy for Ulcerative Colitis in Japan: A Web-based 3T SurveyShunichi Yanai, Yosuke Toya, Shotaro Nakamura, et al.Crohn'S & Colitis 360|September 1, 2022
A Cohort Study of the Age at Menopause in Female Patients With and Without Inflammatory Bowel DiseaseVarun P Moktan, Nader D Daoud, William J Tremaine, et al.Crohn'S & Colitis 360|September 5, 2022
Adalimumab Is Associated With Lower Healthcare Resource and Steroid Use Versus Vedolizumab in Biologic-Naive Crohn's Disease: A Retrospective Claims Database AnalysisRyan C Ungaro, Jenny Griffith, Viviana Garcia-Horton, et al.Crohn'S & Colitis 360|August 20, 2019
Immunologic Alterations Associated With Oral Delivery of Anti-CD3 (OKT3) Monoclonal Antibodies in Patients With Moderate-to-Severe Ulcerative ColitisElisa K Boden, James B Canavan, Christopher J Moran, et al.Crohn'S & Colitis 360|November 22, 2021
Silent Inflammatory Bowel DiseaseMatthew D Coates, David G BinionCrohn'S & Colitis 360|November 22, 2021
Home Infusions for Inflammatory Bowel Disease Are Safe: US Experience and Patient PerspectivesBharati Kochar, Yue Jiang, Wenli Chen, et al.Crohn'S & Colitis 360|January 21, 2025
Exit Interviews Exploring Patients' Experience of Change in Crohn's Disease Symptoms During the Mirikizumab Phase 3 Clinical Trial In Adult Patients With Moderately-to-Severely Crohn's DiseaseTheresa Hunter Gibble, Jake Macey, Harriet Makin, et al.Pageof 52